Literature DB >> 9431842

A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension.

S Schmidt1, J Beige, M Walla-Friedel, M C Michel, A M Sharma, E Ritz.   

Abstract

BACKGROUND: A mutation in the gene for the angiotensin II type 1 (AT1) receptor (A1166C) has been reported to be associated with primary hypertension.
OBJECTIVE: To determine whether this observation could be confirmed with a different population sample.
DESIGN: We examined 414 individuals with primary hypertension and 172 normotensive controls.
METHODS: The mutation in the gene for the AT1 receptor was detected using restriction polymerase chain reaction.
CONCLUSIONS: We detected no association of the AT1 receptor polymorphism with hypertension, but a trend towards a decreased prevalence of the 1166C allele among hypertensive patients with a late age at diagnosis (> or = 50 years) was observed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9431842     DOI: 10.1097/00004872-199715120-00003

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  17 in total

1.  Catalog of 178 variations in the Japanese population among eight human genes encoding G protein-coupled receptors (GPCRs).

Authors:  Susumu Saito; Aritoshi Iida; Akihiro Sekine; Saori Kawauchi; Shoko Higuchi; Chie Ogawa; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-08-30       Impact factor: 3.172

2.  A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene.

Authors:  Gen Kobashi; Akira Hata; Kaori Ohta; Hideto Yamada; Emi Hirayama Kato; Hisanori Minakami; Seiichiro Fujimoto; Kiyotaro Kondo
Journal:  J Hum Genet       Date:  2004-03-23       Impact factor: 3.172

Review 3.  Catecholamines and angiotensinogen gene expression in kidney proximal tubular cells.

Authors:  J S Chan; T T Wang; S L Zhang; X Chen; S Carrière
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 4.  Genetics of arterial hypertension and hypotension.

Authors:  Dieter Rosskopf; Markus Schürks; Christian Rimmbach; Rafael Schäfers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-30       Impact factor: 3.000

5.  Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure.

Authors:  Marcin Zakrzewski-Jakubiak; Simon de Denus; Marie-Pierre Dubé; François Bélanger; Michel White; Jacques Turgeon
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

6.  Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes.

Authors:  Praveen Sethupathy; Christelle Borel; Maryline Gagnebin; Gregory R Grant; Samuel Deutsch; Terry S Elton; Artemis G Hatzigeorgiou; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2007-07-12       Impact factor: 11.025

7.  Genes of renin angiotensin system and coronary heart disease.

Authors:  T F Ashavaid; K K Shalia; K G Nair; J J Dalal
Journal:  Indian J Clin Biochem       Date:  2000-08

Review 8.  Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients.

Authors:  R Büscher; U Vester; A-M Wingen; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2004-11       Impact factor: 3.714

9.  Association of Polymorphisms in Endothelial Nitric Oxide Synthesis and Renin-Angiotensin-Aldosterone System with Developing of Coronary Artery Disease in Bulgarian Patients.

Authors:  Katya Mokretar; Hristo Velinov; Arman Postadzhiyan; Margarita Apostolova
Journal:  Genet Test Mol Biomarkers       Date:  2015-12-15

Review 10.  Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review.

Authors:  Amy K Mottl; David A Shoham; Kari E North
Journal:  Genet Med       Date:  2008-08       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.